NM-3 analogs

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameNM-3 analogs
Drug Alias NameILX-1841ILX-1850ILX-1858ILX-1886ILX-1891 +[27] 
ClassificationSmall molecules
Mechanisms of ActionAnticancer protein kinase inhibitorsVascular endothelial growth factor receptor antagonistsAngiogenesis inhibitors
TargetsVascular endothelial growth factor receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesILEX Oncology Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesILEX Oncology Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A